Camurus — Investor Relations & Filings
Camurus is a science-led biopharmaceutical company that develops and commercializes innovative, long-acting medicines for severe and chronic diseases. The company specializes in advanced drug delivery systems designed to improve treatment outcomes, enhance patient quality of life, and provide value to society. Its therapeutic focus areas include opioid dependence, cancer and supportive care, endocrine conditions, rare diseases, and disorders of the central nervous system. Camurus maintains a diversified research and development pipeline to address significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Interim / Quarterly Report 2026 | 2026-05-12 | Swedish | |
| Interim / Quarterly Report 2026 | 2026-05-12 | English | |
| Annual Report (ESEF) 2025 | 2026-04-29 | Swedish | |
| Förändring av antalet aktier och röster i Camurus | 2026-03-31 | Swedish | |
| Change in number of shares and votes in Camurus | 2026-03-31 | English | |
| Interim / Quarterly Report 2025 | 2026-02-12 | Swedish |
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Camurus, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AMGEN INC
A biotechnology company developing human therapeutics for s…
|
AMGN | US | Manufacturing |
|
Amicogen, Inc.
Industrial biotechnology company specializing in specialty …
|
092040 | KR | Manufacturing |
|
AMICUS THERAPEUTICS, INC.
Biotechnology company developing therapies for rare genetic…
|
FOLD | US | Manufacturing |
|
AMINOLOGICS CO.,LTD.
Specialty manufacturer of high-purity chiral amino acids an…
|
074430 | KR | Manufacturing |
|
Amneal Pharmaceuticals, Inc.
Develops, manufactures, and distributes generic and special…
|
AMRX | US | Manufacturing |
|
Amoy Diagnostics Co.,Ltd.
Develops molecular diagnostic kits and companion diagnostic…
|
300685 | CN | Manufacturing |
|
Amphastar Pharmaceuticals, Inc.
Develops, manufactures, and markets technically challenging…
|
AMPH | US | Manufacturing |
|
Amrutanjan Health Care Limited
Develops and distributes over-the-counter healthcare and pe…
|
AMRUTANJAN | IN | Manufacturing |
|
Amwill Health Care Limited
Develops, manufactures, and distributes a wide range of med…
|
544353 | IN | Manufacturing |
|
Amylyx Pharmaceuticals, Inc.
Develops therapies for neurodegenerative diseases and other…
|
AMLX | US | Manufacturing |
Camurus via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/3021/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=3021 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=3021 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=3021 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 3021}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Camurus (id: 3021)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.